Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015448452> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W3015448452 endingPage "7" @default.
- W3015448452 startingPage "1" @default.
- W3015448452 abstract "Immunotherapy enhances a patient's own immune system to fight against malignancy and has become increasingly popular during the last decade. Tumor cells can escape destruction by the patient's immune system by overexpression of immunosuppressive molecules such as cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), programmed cell death-1 (PD-1) receptor, and its ligand PD-L1. Immunotherapy agents target these inhibitors and basically reactivate the cytotoxic lymphocytes to destroy the tumor cells. Immunotherapy agents currently are FDA-approved for advanced malignancies including melanoma, Hodgkin lymphoma, head and neck squamous cell carcinoma, non-small cell lung cancer, and renal cell carcinoma. In addition, they have shown beneficial promise in the treatment of other malignancies such as high-grade gliomas.1 As of 2018, the common immune checkpoint blocking antibodies approved by the FDA for immunotherapy include ipilimumab, nivolumab, and pembrolizumab; however, exponential growth of these agents is expected in the next few years when many new agents will receive approval and cover a wider range of malignancies. Considering that immunotherapy seeks to harness the patient's own immune system to fight cancer, increased inflammatory changes are expected. The inflammatory changes may involve the skin, gastrointestinal tract, liver, endocrine, and neurologic systems and together are known as immune-related adverse events (irAEs)." @default.
- W3015448452 created "2020-04-17" @default.
- W3015448452 creator A5034086275 @default.
- W3015448452 creator A5041309043 @default.
- W3015448452 creator A5057512038 @default.
- W3015448452 creator A5062908529 @default.
- W3015448452 creator A5083814502 @default.
- W3015448452 date "2020-05-15" @default.
- W3015448452 modified "2023-09-23" @default.
- W3015448452 title "Neurologic Complications of Immunotherapy" @default.
- W3015448452 cites W1969965329 @default.
- W3015448452 cites W2370787112 @default.
- W3015448452 cites W2521728442 @default.
- W3015448452 cites W2557614618 @default.
- W3015448452 cites W2569887568 @default.
- W3015448452 cites W2751194061 @default.
- W3015448452 cites W2756666776 @default.
- W3015448452 cites W2783137027 @default.
- W3015448452 cites W2789807515 @default.
- W3015448452 cites W2890965651 @default.
- W3015448452 doi "https://doi.org/10.1097/01.cdr.0000661748.95847.23" @default.
- W3015448452 hasPublicationYear "2020" @default.
- W3015448452 type Work @default.
- W3015448452 sameAs 3015448452 @default.
- W3015448452 citedByCount "0" @default.
- W3015448452 crossrefType "journal-article" @default.
- W3015448452 hasAuthorship W3015448452A5034086275 @default.
- W3015448452 hasAuthorship W3015448452A5041309043 @default.
- W3015448452 hasAuthorship W3015448452A5057512038 @default.
- W3015448452 hasAuthorship W3015448452A5062908529 @default.
- W3015448452 hasAuthorship W3015448452A5083814502 @default.
- W3015448452 hasConcept C121608353 @default.
- W3015448452 hasConcept C126322002 @default.
- W3015448452 hasConcept C143998085 @default.
- W3015448452 hasConcept C154317977 @default.
- W3015448452 hasConcept C185592680 @default.
- W3015448452 hasConcept C202751555 @default.
- W3015448452 hasConcept C203014093 @default.
- W3015448452 hasConcept C2777701055 @default.
- W3015448452 hasConcept C2777742743 @default.
- W3015448452 hasConcept C2780030458 @default.
- W3015448452 hasConcept C2780057760 @default.
- W3015448452 hasConcept C2780674031 @default.
- W3015448452 hasConcept C2781433595 @default.
- W3015448452 hasConcept C502942594 @default.
- W3015448452 hasConcept C55493867 @default.
- W3015448452 hasConcept C71924100 @default.
- W3015448452 hasConcept C8891405 @default.
- W3015448452 hasConceptScore W3015448452C121608353 @default.
- W3015448452 hasConceptScore W3015448452C126322002 @default.
- W3015448452 hasConceptScore W3015448452C143998085 @default.
- W3015448452 hasConceptScore W3015448452C154317977 @default.
- W3015448452 hasConceptScore W3015448452C185592680 @default.
- W3015448452 hasConceptScore W3015448452C202751555 @default.
- W3015448452 hasConceptScore W3015448452C203014093 @default.
- W3015448452 hasConceptScore W3015448452C2777701055 @default.
- W3015448452 hasConceptScore W3015448452C2777742743 @default.
- W3015448452 hasConceptScore W3015448452C2780030458 @default.
- W3015448452 hasConceptScore W3015448452C2780057760 @default.
- W3015448452 hasConceptScore W3015448452C2780674031 @default.
- W3015448452 hasConceptScore W3015448452C2781433595 @default.
- W3015448452 hasConceptScore W3015448452C502942594 @default.
- W3015448452 hasConceptScore W3015448452C55493867 @default.
- W3015448452 hasConceptScore W3015448452C71924100 @default.
- W3015448452 hasConceptScore W3015448452C8891405 @default.
- W3015448452 hasIssue "10" @default.
- W3015448452 hasLocation W30154484521 @default.
- W3015448452 hasOpenAccess W3015448452 @default.
- W3015448452 hasPrimaryLocation W30154484521 @default.
- W3015448452 hasRelatedWork W2285109017 @default.
- W3015448452 hasRelatedWork W2332168583 @default.
- W3015448452 hasRelatedWork W2339776053 @default.
- W3015448452 hasRelatedWork W2968490685 @default.
- W3015448452 hasRelatedWork W3015448452 @default.
- W3015448452 hasRelatedWork W3104083510 @default.
- W3015448452 hasRelatedWork W3119432592 @default.
- W3015448452 hasRelatedWork W3154458198 @default.
- W3015448452 hasRelatedWork W3170189973 @default.
- W3015448452 hasRelatedWork W4366813062 @default.
- W3015448452 hasVolume "43" @default.
- W3015448452 isParatext "false" @default.
- W3015448452 isRetracted "false" @default.
- W3015448452 magId "3015448452" @default.
- W3015448452 workType "article" @default.